Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2025Earnings Conference Call November 13, 2024 4:30 PM ET
Company Participants
Michael Miller – Investor Relations, Rx Communications
James Frakes – Interim Chief Executive Officer & Chief Financial Officer
Steven LaRosa – Chief Medical Officer
Conference Call Participants
Marla Marin – Zacks
Jeremy Pearlman – Maxim Group
Operator
Good day, and welcome to the Aethlon Medical Fiscal Second Quarter 2025 Earnings and Corporate Update. [Operator Instructions] Please note this event is being recorded.
I would now like to turn the conference over to Michael Miller with Rx Communications. Please go ahead.
Michael Miller
Thank you, operator, and good afternoon, everyone. Welcome to Aethlon Medical’s fiscal second quarter 2025 earnings conference call. My name is Michael Miller with Rx Communications. At 4:15 p.m. Eastern Time today, Aethlon Medical released financial results for its fiscal second quarter ended September 30, 2024. If you have not seen or received Aethlon Medical’s earnings release, please visit the Investors page at www.aethlonmedical.com to view it. Following this introduction and the reading of the company’s forward-looking statement disclaimer, Aethlon’s Chief Executive Officer and Chief Financial Officer, James Frakes; and Aethlon’s Chief Medical Officer, Dr. Steven LaRosa, will provide an overview of Aethlon’s strategy and recent developments. Mr. Frakes will then make some brief remarks on Aethlon’s financials. We will then open up the call for the Q&A session.
Before I hand the call over to Mr. Frakes, please note that the news release today and this call contain forward-looking statements within the meaning of the Securities Act of 1933 as amended and the Securities Exchange Act of 1934 as amended. The company cautions you that any statement that is not a statement of historical fact is a forward-looking statement. These statements are based on expectations and assumptions as of the date of this conference call. Such
